Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC N-[4-[(E)-2-[3-t-Bu-5-(2,4-dioxopyrimidin-1-yl)-2-methoxyphenyl]ethenyl]phenyl]methanesulfonamide | 1132936-00-5 | MFCD28502074 | 99.8% | 469.55 g/mol | C24H27N3O5S | 25 MG
SDP

Catalog No. 5000248506
Encompass_Preferred

ABT-072 is an orally active, non-nucleoside inhibitor of the hepatitis C virus NS5B RNA-dependent RNA polymerase. It exhibits nanomolar in vitro potency against genotype 1a and 1b polymerases and showed favorable pharmacokinetics in preclinical studies, including low plasma clearance and good oral bioavailability.

  • Orally active non-nucleoside NS5B polymerase inhibitor.
  • Nanomolar potency against HCV genotype 1a and 1b (EC50 values reported).
  • Favorable pharmacokinetic profile in preclinical species.
  • High chemical purity suitable for research applications.
  • Solid, off-white to yellow appearance.
  • Stable under recommended cold storage conditions.

Catalog No. 50-002-48506 Supplier Medchemexpress LLC Supplier No. HY10163425MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ABT-072 is an orally active, non-nucleoside inhibitor of the hepatitis C virus NS5B RNA-dependent RNA polymerase. It exhibits nanomolar in vitro potency against genotype 1a and 1b polymerases and showed favorable pharmacokinetics in preclinical studies, including low plasma clearance and good oral bioavailability.

  • Orally active non-nucleoside NS5B polymerase inhibitor.
  • Nanomolar potency against HCV genotype 1a and 1b (EC50 values reported).
  • Favorable pharmacokinetic profile in preclinical species.
  • High chemical purity suitable for research applications.
  • Solid, off-white to yellow appearance.
  • Stable under recommended cold storage conditions.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.